Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

UFPT vs WINA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

WINA Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 7–3 Matrix Metrics)

WINA Overall Winner 6-Pillar Tally: UFPT 1 – 4 WINA (1 Tie) Matrix Metrics: UFPT 3 – 7 WINA

As of Nov 16, 2026, Winmark Corp (WINA) is the stronger overall head-to-head candidate over UFP Technologies Inc (UFPT) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). UFPT carries a Unified Composite Score of 42.6/100 (HOLD) at $298.54 (24.7x Forward P/E, 15.4% operating margin), whereas WINA carries 47.9/100 (HOLD) at $268.33 (24.1x Forward P/E, 59.7% operating margin).

  • Technical & Structure Timing Caution: UFPT is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.8); meanwhile WINA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About UFPT vs WINA
UFPT NASDAQ
UFP Technologies Inc
Surgical & Medical Instruments & Apparatus
$298.54
-2.14% 1D
Market Cap $2.4B
TTM Revenue $650M
Forward P/E 24.7x
Beta / 30D Vol 1.64β · 77% Vol
Unified Composite Score
42.6 / 100 HOLD
Tech 25.0 Fund 37.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -1.1%) with fading momentum, RSI 50
RSI-14: 49.8 · SMA20: $298.97 · SMA50: $293.17
WINA NASDAQ Head-to-Head Winner
Winmark Corp
Retail-Miscellaneous Retail
$268.33
-1.23% 1D
Market Cap $966.9M
TTM Revenue $92M
Forward P/E 24.1x
Beta / 30D Vol 0.53β · 42% Vol
Unified Composite Score
47.9 / 100 HOLD
Tech 43.0 Fund 61.0 Flow 50.0 Mom 68.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -8.2%), weak momentum, RSI 39
RSI-14: 39.0 · SMA20: $278.33 · SMA50: $290.47

6-Pillar Scorecard Institutional Category Breakdown (UFPT 1 – 4 WINA)

Columns: Metric · UFPT · WINA
1. Valuation Multiples WINA
Forward P/E 24.7x 24.1x
Trailing P/E 31.2x 24.3x
PEG Ratio 3.80x 1.41x
EV / Revenue 3.6x 10.5x
2. Growth & Scale UFPT
Revenue Growth (YoY) +11.6% +23.2%
Earnings Growth (YoY) +25.1% +6.3%
TTM Revenue (USD) $650M $92M
Market Cap $2.4B $966.9M
3. Profitability & Quality WINA
Gross Margin 28.9% 92.4%
Operating Margin 15.4% 59.7%
Net Profit Margin 11.8% 45.1%
Return on Equity (ROE) 17.2% 0.0%
4. Balance Sheet & Cash Flow WINA
Cash Generation (TTM) $120M EBITDA $56M EBITDA
Cash Flow Margin 18.5% EBITDA Mgn 60.5% EBITDA Mgn
Net Cash / Leverage $62.70 Book/Sh · 17.2% ROE 0.0% ROE
Dividend Yield None (0.00%) 1.46%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 42.3% (3rd %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Markdown
6. R&D & Supply-Chain Moat WINA
OpEx & R&D Intensity 13.5% of Rev ($88M) 32.7% of Rev ($30M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat High-Margin Pricing Power Moat
Supply-Chain Role Medical Devices Operator Specialty Retail Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: UFPT (3) vs WINA (7)
Institutional Metric UFPT WINA Criterion Row Edge
Market Capitalization
Scale
$2.4B $966.9M Larger Scale UFPT
Trailing P/E Ratio
Valuation
31.2x 24.3x Lower Multiple WINA
Forward P/E Ratio
Valuation
24.7x 24.1x Lower Multiple WINA
Revenue Growth (YoY)
Growth
+11.6% +23.2% Higher Growth WINA
Operating Margin (TTM)
Profitability
15.4% 59.7% Higher Margin WINA
Net Profit Margin
Profitability
11.8% 45.1% Higher Margin WINA
Return on Equity (ROE)
Capital Efficiency
17.2% 0.0% Higher ROE UFPT
52-Week Range Position
Momentum
74% ($174–$342) 3% ($262–$489) Stronger Trend UFPT
Beta / 30D Volatility
Risk Regime
1.64β · 77% Vol 0.53β · 42% Vol Lower Realized Risk WINA
Unified Institutional Score
Composite Signal
42.6 / 100 (HOLD) 47.9 / 100 (HOLD) Higher Composite WINA
Trailing 12M Revenue (USD)
Operating Scale
$650M $92M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
28.9% 92.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
3.80x PEG · 3.6x EV/Rev 1.41x PEG · 10.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$120M EBITDA ($62.70 Book/Sh · 17.2% ROE) $56M EBITDA (0.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon UFPT +17.13 pp
UFPT: +2.36% · WINA: -14.77%
3M Horizon UFPT +16.92 pp
UFPT: -4.92% · WINA: -21.84%
6M Horizon UFPT +61.44 pp
UFPT: +37.44% · WINA: -24.0%
1Y Horizon UFPT +62.57 pp
UFPT: +27.42% · WINA: -35.15%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UFPT vs WINA. Trailing 12-month operating profitability (UFPT 15.4% vs WINA 59.7%) and valuation multiples (UFPT 24.7x vs WINA 24.1x Forward P/E) are benchmarked directly in Pillar 4 below.

UFPT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$650M
Gross Margin28.9%
Op. Margin15.4%
ROE / Fwd P/E17.2% · 24.7x
WINA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$92M
Gross Margin92.4%
Op. Margin59.7%
ROE / Fwd P/E0.0% · 24.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
UFPT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 42.3%
IV Percentile 3rd %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact UFPT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
WINA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact WINA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
UFPT Moat Profile Scale & Operating Efficiency Moat
Medical Devices Operator
Competes within the Medical Devices value chain with $2.4B market capitalization and 15.4% operating margin.
OpEx & R&D Reinvestment 13.5% of Rev ($88M)
90D Engineering Disclosures 0 Published
WINA Moat Profile High-Margin Pricing Power Moat
Specialty Retail Operator
Competes within the Specialty Retail value chain with $966.9M market capitalization and 59.7% operating margin.
OpEx & R&D Reinvestment 32.7% of Rev ($30M)
90D Engineering Disclosures 0 Published

Investor FAQ UFPT vs WINA Key Questions & Quantitative Answers

As of Nov 16, 2026, Winmark Corp (WINA) is the stronger overall head-to-head candidate over UFP Technologies Inc (UFPT) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). UFPT carries a Unified Composite Score of 42.6/100 (HOLD) at $298.54 (24.7x Forward P/E, 15.4% operating margin), whereas WINA carries 47.9/100 (HOLD) at $268.33 (24.1x Forward P/E, 59.7% operating margin). Technical & Structure Timing Caution: UFPT is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.8); meanwhile WINA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

UFPT leads the Growth & Scale pillar: UFPT posts +11.6% YoY revenue growth and +25.1% YoY earnings growth on $650M TTM revenue (28.9% gross margin, 15.4% operating margin), compared with WINA at +23.2% YoY revenue growth and +6.3% YoY earnings growth on $92M TTM revenue (92.4% gross margin, 59.7% operating margin). On trailing 12-month operating scale, UFPT generates $650M in USD-normalized revenue versus $92M for WINA. In operating R&D and SG&A reinvestment, UFPT deploys 13.5% of Rev ($88M) (0 90-day corporate R&D disclosures) versus 32.7% of Rev ($30M) (0 disclosures) for WINA.

WINA screens cheaper on headline valuation multiples. UFPT trades at 24.7x Forward P/E, 31.2x Trailing P/E, 3.80x PEG, and 3.6x EV/Revenue (18.5% EBITDA margin), whereas WINA trades at 24.1x Forward P/E, 24.3x Trailing P/E, 1.41x PEG, and 10.5x EV/Revenue (60.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against UFPT (17.2% ROE) versus WINA (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, UFPT carries 42.3% implied volatility (3rd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.64β · 77% Vol realized risk). By comparison, WINA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.53β · 42% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.